Page last updated: 2024-09-02

oxymatrine and Cancer of Head

oxymatrine has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lin, Y; Lin, Z; Luo, R; Shao, J; Xie, L	1

Other Studies

1 other study(ies) available for oxymatrine and Cancer of Head

Article	Year
Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m Oncology reports, 2022, Volume: 48, Issue:4 Topics: Alkaloids; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Methyltransferases; Mouth Neoplasms; Quinolizines; Receptors, CXCR4; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck	2022

Article

Year

Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m

Oncology reports, 2022, Volume: 48, Issue:4

Topics: Alkaloids; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Methyltransferases; Mouth Neoplasms; Quinolizines; Receptors, CXCR4; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck

2022